Market Analysis

May 2014

Vascular Access Devices | Europe | 2014 | Market Analysis

Introduction:

Overall, rising unit sales—predominantly due to an aging population—and the uptake of premium-priced products will spur revenue growth in the European vascular access device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for vascular access devices in Europe across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   Short PIVCs are available as safety and ported devices throughout Europe.

How are national initiatives to reduce needlestick injuries—encouraged by the EU sharps directive—affecting safety device usage in the various short PIVC markets?

How often are ported devices used, and how will market growth differ between ported and nonported devices?

  *   The risk of catheter-related BSIs is a prominent issue in the vascular access device space, and reducing this risk will continue to be a focus of health care facilities and manufacturers.

How will device usage shift between short PIVCs, PICCs, CVCs, and implantable ports?

How does the adoption of PICCs vary between countries and what factors are responsible for the differences?

How will the markets for antimicrobial CVCs and dialysis catheters perform through 2022?

  *   Adoption of premium-priced products varies by country and will affect market growth and competitive dynamics.

How will adoption of power-injectable PICCs, implantable ports, and Huber needles change over the forecast period, and how will this affect unit sales and revenues in these markets?

To what extent are new antithrombogenic PICCs being adopted in Europe?

How will the usage of implantable ports be affected by changes in PICC usage?

How will the various vascular access device markets be affected by the introduction of novel technologies?

Scope:

Geographies Covered: France, Italy, Germany, Spain, UK

Products Covered: Millennium Research Group's analysis uses the following breakdown of products in the market:

Product Type

Short PIVCs

Product Type

Standard

Safety

Product Design

Ported

Nonported

PICCs

CVCs

Product Type

Acute

Product Type

Standard

Antimicrobial

Product Design

Single-Lumen

Double-Lumen

Triple-Lumen

Quad-Lumen

Quint-Lumen

Tunneled

Dialysis Catheters

Product Type

Acute

Product Type

Standard

Antimicrobial

Tunneled

Implantable Ports

Product Design

Single-Lumen

Double-Lumen

Material

Titanium

Plastic

Huber Needles

Product Type

Conventional

Safety

In the "Dialysis Catheter Market" chapter, the ESRD incident and prevalent populations are shown, along with the ESRD treatment types and modes of vascular access for ESRD hemodialysis cases.

ESRD Treatments Covered

Patients

Population

Incident

Prevalent

Treatment Type

Hemodialysis

Initial and Follow-Up Mode of Vascular Access

Dialysis Catheter

AV Fistula

AV Graft

PD

Kidney Transplant

Note: Initial mode refers to the initial mode of vascular access; follow-up mode refers to the mode of vascular access after 90 days.

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in unit sales, ASPs, and market values over a 10-year period (2012–2022).

Authors:

Jonathan Sawatsky, M.Biotech

Contributors
April Chan
Steve Edgar, M.A.
Karen Gierszewski
Samuli Heilala, M.Sc.
Kathleen Zorzella



Search Reports

Mentioned in this report:

  • AngioDynamics
  • Argon Medical Devices
  • Artsana
  • Baxter
  • B. Braun
  • BD
  • Bellco
  • Cook Medical
  • Covidien
  • C. R. Bard
  • CryoLife
  • DELTA MED
  • Edwards Lifesciences
  • Fresenius Medical Care
  • Hancock Jaffe Laboratories
  • Health Line International
  • Hemosphere
  • Interface Biologics
  • Joline
  • Medcomp
  • Medline Industries
  • PEROUSE MEDICAL
  • pfm medical
  • Plan 1 Health
  • POLYMED
  • PRODIMED
  • r4 Vascular
  • Semprus BioSciences
  • Smiths Medical
  • Teleflex Medical
  • Terumo
  • Vygon
  • W. L. Gore
Decision Resources Group brands include: